Director/PDMR Share Dealing
No summary for this filing – the full text is below.
Select text to share a quote on X · sign in to keep highlights & notes in your CREO notes
Creo Medical Group plc (AIM: CREO), the medical device company focused on the emerging field of minimally invasive surgical endoscopy for pre-cancer and cancer patients, was informed on 8 August 2025 that Richard Rees, Chief Financial Officer of the Company, passed the control of 362,408 ordinary shares of 0.1 pence each in the Company ("Ordinary Shares") to three of his children who are now aged eighteen or older.
Consequently, Mr Rees's total beneficial interest in the Company has reduced by 362,408 Ordinary Shares to 2,707,555 1 Ordinary Shares, representing approximately 0.66% of the Company's issued share capital.
1 Including shares held by certain other PCAs of Mr Rees
| 1 | Details of the person discharging managerial responsibilities / person closely associated | ||
| a) | Name | Richard John Rees | |
| 2 | Reason for the notification | ||
| a) | Position/status | Chief Finance Officer | |
| b) | Initial notification/Amendment | Initial Notification | |
| a) | Name | Creo Medical Group plc | |
| b) | LEI | 213800H188ZDCWWXFA21 | |
| a) | Description of the financial instrument, type of instrument | Ordinary shares of £0.001 each | |
| Identification code | GB00BZ1BLL44 | ||
| b) | Nature of the transaction | Transfer of Ordinary Shares | |
| c) | Price(s) and volumes(s) | Price(s) | Volume(s) |
| Nil | 167,038 | ||
| d) | Aggregated information | ||
| Aggregated volume | 167,038 | ||
| Price | Nil | ||
| e) | Date of the transaction | 8 August 2025 | |
| f) | Place of the transaction | London Stock Exchange | |
| 1 | Details of the person discharging managerial responsibilities / person closely associated | ||
| a) | Name | Richard John Rees | |
| 2 | Reason for the notification | ||
| a) | Position/status | Chief Finance Officer | |
| b) | Initial notification/Amendment | Initial Notification | |
| a) | Name | Creo Medical Group plc | |
| b) | LEI | 213800H188ZDCWWXFA21 | |
| a) | Description of the financial instrument, type of instrument | Ordinary shares of £0.001 each | |
| Identification code | GB00BZ1BLL44 | ||
| b) | Nature of the transaction | Transfer of Ordinary Shares | |
| c) | Price(s) and volumes(s) | Price(s) | Volume(s) |
| Nil | 121,086 | ||
| d) | Aggregated information | ||
| Aggregated volume | 121,086 | ||
| Price | Nil | ||
| e) | Date of the transaction | 8 August 2025 | |
| f) | Place of the transaction | London Stock Exchange | |
| 1 | Details of the person discharging managerial responsibilities / person closely associated | ||
| a) | Name | Richard John Rees | |
| 2 | Reason for the notification | ||
| a) | Position/status | Chief Finance Officer | |
| b) | Initial notification/Amendment | Initial Notification | |
| a) | Name | Creo Medical Group plc | |
| b) | LEI | 213800H188ZDCWWXFA21 | |
| a) | Description of the financial instrument, type of instrument | Ordinary shares of £0.001 each | |
| Identification code | GB00BZ1BLL44 | ||
| b) | Nature of the transaction | Transfer of Ordinary Shares | |
| c) | Price(s) and volumes(s) | Price(s) | Volume(s) |
| Nil | 74,284 | ||
| d) | Aggregated information | ||
| Aggregated volume | 74,284 | ||
| Price | Nil | ||
| e) | Date of the transaction | 8 August 2025 | |
| f) | Place of the transaction | London Stock Exchange |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.